Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2311-2320 of 2762 for

Edit search filters
  1. Cutaneous Lymphoma Biobank Study

    Scottsdale/Phoenix, AZ

  2. Brain MRE at 7T

    Rochester, MN

  3. A Study to Evaluate Family Member Exposure to Antineoplastic Drugs in the Home Setting

    Eau Claire, WI

  4. Mayo Clinic Cancer Genomics Service Line Biorepository

    Eau Claire, WI, Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study to Evaluate Diarrhea in Patients with Multiple Myeloma Receiving Conditioning Chemotherapy for Autologous Stem Cell Transplantation (SCT)

    Rochester, MN

  6. A Study to Establish a Research Tissue Bank for Myeloproliferative Neoplasms

    Scottsdale/Phoenix, AZ

  7. The National Myelodysplastic Syndromes (MDS) Study

    La Crosse, WI, Jacksonville, FL

  8. Collection of Term Placenta for Development of Trophoblast Cell Culture

    Rochester, MN

  9. Plasma Proneurotensin as a Predictive Biomarker for Breast Cancer in Genetically Predisposed Patients

    Rochester, MN

  10. ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain

    Rochester, MN

.

Mayo Clinic Footer